A single dose of Pfizer’s (PFE.N) coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19, according to a UK study published on…
Risk from virus variants remains after first Pfizer COVID-19 vaccine, UK study finds
